An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen

This study has been completed.

Study NCT00344383 Information provided by McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

First Received: June 23, 2006 Last Updated: October 19, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	July 2004
Estimated Primary Completion Date:	No date given